Skip to Content

Esmolol Injection

Last Updated: April 7, 2015
Status: Resolved

Products Affected - Description

Esmolol injection, West-Ward
10 mg/mL single-dose vial, package of 10 (NDC 55390-0062-10)

Reason for the Shortage

West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired esmolol injection from Bedford in July 2014. West-Ward is not actively marketing esmolol injection at this time.

Available Products

Brevibloc premix, Baxter
10 mg/mL, 250 mL, package of 10 (NDC 10019-0055-61)

20 mg/mL, 100 mL, package of 10 (NDC 10019-0075-87)  
 
Esmolol injection, Baxter
10 mg/mL, 10 mL single-dose vial, package of 25 (NDC 10019-0120-01)
10 mg/mL, 10 mL single-dose vial, package of 100 (NDC 10019-0115-01)

Esmolol injection, Fresenius Kabi
10 mg/mL, 10 mL single-dose vial, package of 25, NDC 63323-0652-10

Esmolol injection, Mylan Institutional
10 mg/mL, 10 mL single-dose vial, package of 10, NDC 67457-0182-10

Estimated Resupply Dates

All marketed presentations are available at this time.

Related Shortages

Updated

April 7, March 9, February 12 and 24, January 16, 2015; November 6, August 8, May 8, February 5, 2014; December 18, November 6, October 24, September 3 and 12, July 10 and 18, May 10 and 22, March 14, February 13, January 2 and 11, 2013; December 14, November 2, October 4, September 12, July 25, June 5, May 8 and 21, April 4,12, and 23, March 19, February 16 and 29, January 6, 2012; December 2, October 4 and 19, September 21, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide